Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Jun;63(6):616–620. doi: 10.1136/ard.2003.019497

Central nervous system involvement in Sjögren's syndrome

F Soliotis 1, C Mavragani 1, H Moutsopoulos 1
PMCID: PMC1755013  PMID: 15140765

Full Text

The Full Text of this article is available as a PDF (71.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander E. L., Beall S. S., Gordon B., Selnes O. A., Yannakakis G. D., Patronas N., Provost T. T., McFarland H. F. Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. Ann Intern Med. 1988 Jun;108(6):815–823. doi: 10.7326/0003-4819-108-6-815. [DOI] [PubMed] [Google Scholar]
  2. Alexander E. L., Lijewski J. E., Jerdan M. S., Alexander G. E. Evidence of an immunopathogenic basis for central nervous system disease in primary Sjögren's syndrome. Arthritis Rheum. 1986 Oct;29(10):1223–1231. doi: 10.1002/art.1780291007. [DOI] [PubMed] [Google Scholar]
  3. Alexander E. L., Malinow K., Lejewski J. E., Jerdan M. S., Provost T. T., Alexander G. E. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med. 1986 Mar;104(3):323–330. doi: 10.7326/0003-4819-104-3-323. [DOI] [PubMed] [Google Scholar]
  4. Alexander E. L. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am. 1993 Nov;19(4):869–908. [PubMed] [Google Scholar]
  5. Alexander E. L., Ranzenbach M. R., Kumar A. J., Kozachuk W. E., Rosenbaum A. E., Patronas N., Harley J. B., Reichlin M. Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology. 1994 May;44(5):899–908. doi: 10.1212/wnl.44.5.899. [DOI] [PubMed] [Google Scholar]
  6. Alexander E. Central nervous system disease in Sjögren's syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am. 1992 Aug;18(3):637–672. [PubMed] [Google Scholar]
  7. Andonopoulos A. P., Lagos G., Drosos A. A., Moutsopoulos H. M. The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol. 1990 Feb;29(1):21–23. doi: 10.1093/rheumatology/29.1.21. [DOI] [PubMed] [Google Scholar]
  8. Awad I. A., Spetzler R. F., Hodak J. A., Awad C. A., Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke. 1986 Nov-Dec;17(6):1084–1089. doi: 10.1161/01.str.17.6.1084. [DOI] [PubMed] [Google Scholar]
  9. Belin C., Moroni C., Caillat-Vigneron N., Debray M., Baudin M., Dumas J. L., Moretti J. L., Delaporte P., Guillevin L. Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT. Ann Med Interne (Paris) 1999 Dec;150(8):598–604. [PubMed] [Google Scholar]
  10. Binder A., Snaith M. L., Isenberg D. Sjögren's syndrome: a study of its neurological complications. Br J Rheumatol. 1988 Aug;27(4):275–280. doi: 10.1093/rheumatology/27.4.275. [DOI] [PubMed] [Google Scholar]
  11. Canhão H., Fonseca J. E., Rosa A. Intravenous gammaglobulin in the treatment of central nervous system vasculitis associated with Sjögren's syndrome. J Rheumatol. 2000 Apr;27(4):1102–1103. [PubMed] [Google Scholar]
  12. Celius E. G., Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol. 2001 Sep;8(5):463–469. doi: 10.1046/j.1468-1331.2001.00269.x. [DOI] [PubMed] [Google Scholar]
  13. Cervera R., García-Carrasco M., Font J., Ramos M., Reverter J. C., Muñoz F. J., Miret C., Espinosa G., Ingelmo M. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol. 1997 Jul-Aug;15(4):361–365. [PubMed] [Google Scholar]
  14. Coates T., Slavotinek J. P., Rischmueller M., Schultz D., Anderson C., Dellamelva M., Sage M. R., Gordon T. P. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. J Rheumatol. 1999 Jun;26(6):1301–1305. [PubMed] [Google Scholar]
  15. Collard R. C., Koehler R. P., Mattson D. H. Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology. 1997 Sep;49(3):857–861. doi: 10.1212/wnl.49.3.857. [DOI] [PubMed] [Google Scholar]
  16. Drosos A. A., Andonopoulos A. P., Lagos G., Angelopoulos N. V., Moutsopoulos H. M. Neuropsychiatric abnormalities in primary Sjögren's syndrome. Clin Exp Rheumatol. 1989 Mar-Apr;7(2):207–209. [PubMed] [Google Scholar]
  17. Ellemann K., Krogh E., Arlien-Soeborg P., Halberg P. Sjögren's syndrome in patients with multiple sclerosis. Acta Neurol Scand. 1991 Jul;84(1):68–69. doi: 10.1111/j.1600-0404.1991.tb04906.x. [DOI] [PubMed] [Google Scholar]
  18. Escudero D., Latorre P., Codina M., Coll-Cantí J., Coll J. Central nervous system disease in Sjögren's syndrome. Ann Med Interne (Paris) 1995;146(4):239–242. [PubMed] [Google Scholar]
  19. Govoni M., Bajocchi G., Rizzo N., Tola M. R., Caniatti L., Tugnoli V., Colamussi P., Trotta F. Neurological involvement in primary Sjögren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol. 1999;18(4):299–303. doi: 10.1007/s100670050105. [DOI] [PubMed] [Google Scholar]
  20. Govoni M., Padovan M., Rizzo N., Trotta F. CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs. 2001;15(8):597–607. doi: 10.2165/00023210-200115080-00003. [DOI] [PubMed] [Google Scholar]
  21. Hietaharju A., Jäntti V., Korpela M., Frey H. Nervous system involvement in systemic lupus erythematosus, Sjögren syndrome and scleroderma. Acta Neurol Scand. 1993 Oct;88(4):299–308. doi: 10.1111/j.1600-0404.1993.tb04241.x. [DOI] [PubMed] [Google Scholar]
  22. Hietaharju A., Yli-Kerttula U., Häkkinen V., Frey H. Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand. 1990 Feb;81(2):144–152. doi: 10.1111/j.1600-0404.1990.tb00951.x. [DOI] [PubMed] [Google Scholar]
  23. Ioannidis J. P., Moutsopoulos H. M. Sjögren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. Semin Arthritis Rheum. 1999 Aug;29(1):1–3. doi: 10.1016/s0049-0172(99)80032-8. [DOI] [PubMed] [Google Scholar]
  24. Jedryka-Goral A., Jagiello P., D'Cruz D. P., Maldykowa H., Khamashta M. A., Hughes G. R., Swana G. T., Luft S. Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis. 1992 Jul;51(7):889–891. doi: 10.1136/ard.51.7.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Johnson E. O., Vlachoyiannopoulos P. G., Skopouli F. N., Tzioufas A. G., Moutsopoulos H. M. Hypofunction of the stress axis in Sjögren's syndrome. J Rheumatol. 1998 Aug;25(8):1508–1514. [PubMed] [Google Scholar]
  26. Kao C. H., Lan J. L., ChangLai S. P., Chieng P. U. Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome. J Nucl Med. 1998 May;39(5):773–777. [PubMed] [Google Scholar]
  27. Lafitte C., Amoura Z., Cacoub P., Pradat-Diehl P., Picq C., Salachas F., Léger J. M., Piette J. C., Delattre J. Y. Neurological complications of primary Sjögren's syndrome. J Neurol. 2001 Jul;248(7):577–584. doi: 10.1007/s004150170135. [DOI] [PubMed] [Google Scholar]
  28. Malinow K. L., Molina R., Gordon B., Selnes O. A., Provost T. T., Alexander E. L. Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med. 1985 Sep;103(3):344–350. doi: 10.7326/0003-4819-103-3-344. [DOI] [PubMed] [Google Scholar]
  29. Manthorpe R., Manthorpe T., Sjöberg S. Magnetic resonance imaging of the brain in patients with primary Sjögren's syndrome. Scand J Rheumatol. 1992;21(3):148–149. doi: 10.3109/03009749209095089. [DOI] [PubMed] [Google Scholar]
  30. Mauch E., Völk C., Kratzsch G., Krapf H., Kornhuber H. H., Laufen H., Hummel K. J. Neurological and neuropsychiatric dysfunction in primary Sjögren's syndrome. Acta Neurol Scand. 1994 Jan;89(1):31–35. [PubMed] [Google Scholar]
  31. Miró J., Peña-Sagredo J. L., Berciano J., Insúa S., Leno C., Velarde R. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol. 1990 May;27(5):582–584. doi: 10.1002/ana.410270522. [DOI] [PubMed] [Google Scholar]
  32. Moll J. W., Markusse H. M., Pijnenburg J. J., Vecht C. J., Henzen-Logmans S. C. Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome. Neurology. 1993 Dec;43(12):2574–2581. doi: 10.1212/wnl.43.12.2574. [DOI] [PubMed] [Google Scholar]
  33. Moutsopoulos H. M., Sarmas J. H., Talal N. Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am. 1993 Nov;19(4):909–912. [PubMed] [Google Scholar]
  34. Noseworthy J. H., Bass B. H., Vandervoort M. K., Ebers G. C., Rice G. P., Weinshenker B. G., McLay C. J., Bell D. A. The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol. 1989 Jan;25(1):95–98. doi: 10.1002/ana.410250117. [DOI] [PubMed] [Google Scholar]
  35. Pennec Y. L., Magadur G., Jouquan J., Youinou P. Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome. Clin Exp Rheumatol. 1991 Mar-Apr;9(2):165–167. [PubMed] [Google Scholar]
  36. Pierot L., Sauve C., Leger J. M., Martin N., Koeger A. C., Wechsler B., Chiras J. Asymptomatic cerebral involvement in Sjögren's syndrome: MRI findings of 15 cases. Neuroradiology. 1993;35(5):378–380. doi: 10.1007/BF00588375. [DOI] [PubMed] [Google Scholar]
  37. Pérez B., Kraus A., López G., Cifuentes M., Alarcón-Segovia D. Autoimmune thyroid disease in primary Sjögren's syndrome. Am J Med. 1995 Nov;99(5):480–484. doi: 10.1016/s0002-9343(99)80223-x. [DOI] [PubMed] [Google Scholar]
  38. Sanders M. E., Alexander E. L., Koski C. L., Frank M. M., Joiner K. A. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus. J Immunol. 1987 Apr 1;138(7):2095–2099. [PubMed] [Google Scholar]
  39. Scofield R. H. Autoimmune thyroid disease in systemic lupus erythematosus and Sjögren's syndrome. Clin Exp Rheumatol. 1996 May-Jun;14(3):321–330. [PubMed] [Google Scholar]
  40. Spezialetti R., Bluestein H. G., Peter J. B., Alexander E. L. Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med. 1993 Aug;95(2):153–160. doi: 10.1016/0002-9343(93)90255-n. [DOI] [PubMed] [Google Scholar]
  41. Sundström P., Nyström L., Forsgren L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):29–32. doi: 10.1136/jnnp.74.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sánchez J. L., Aguirre C., Arcos-Burgos O. M., Jiménez I., Jiménez M., León F., Pareja J., Pradilla G., Uribe B., Uribe C. S. Prevalencia de la esclerosis múltiple en Colombia. Rev Neurol. 2000 Dec 16;31(12):1101–1103. [PubMed] [Google Scholar]
  43. Tajima Y., Mito Y., Owada Y., Tsukishima E., Moriwaka F., Tashiro K. Neurological manifestations of primary Sjögren's syndrome in Japanese patients. Intern Med. 1997 Oct;36(10):690–693. doi: 10.2169/internalmedicine.36.690. [DOI] [PubMed] [Google Scholar]
  44. Tesar J. T., McMillan V., Molina R., Armstrong J. Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome. Am J Med. 1992 Jun;92(6):686–692. doi: 10.1016/0002-9343(92)90788-d. [DOI] [PubMed] [Google Scholar]
  45. Trojano M., Paolicelli D. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci. 2001 Nov;22 (Suppl 2):S98–102. doi: 10.1007/s100720100044. [DOI] [PubMed] [Google Scholar]
  46. de Andrés C., Guillem A., Rodríguez-Mahou M., López Longo F. J. Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients. Acta Neurol Scand. 2001 Aug;104(2):83–87. doi: 10.1034/j.1600-0404.2001.104002083.x. [DOI] [PubMed] [Google Scholar]
  47. de Seze J., Devos D., Castelnovo G., Labauge P., Dubucquoi S., Stojkovic T., Ferriby D., Vermersch P. The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology. 2001 Oct 23;57(8):1359–1363. doi: 10.1212/wnl.57.8.1359. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES